Plasma DNA methylation detection for early screening, diagnosis, and monitoring of esophageal adenocarcinoma and squamous cell carcinoma
According to our findings, plasma <i>SHOX2</i>, <i>SEPTIN9</i>, <i>RNF180</i>, and <i>EPO</i> methylation exhibits appreciated sensitivity for diagnosing EC. The precise measurement of plasma <i>SHOX2</i>, <i>SEPTIN9</i>, <i>RNF180</i>, and <i>EPO</i> methylation can improve EC diagnosis and therapy efficacy monitoring.
Authors
- X. Liu
- Jinyan Kai (ORCID: https://orcid.org/0000-0002-3610-9230)
- Guoliang Pi (ORCID: https://orcid.org/0000-0002-2740-2857)
- Hongwei Shi (ORCID: https://orcid.org/0000-0002-8760-4733)
- Jing Yu (ORCID: https://orcid.org/0000-0003-0088-7134)
- Sheng Wang (ORCID: https://orcid.org/0000-0003-2696-2171)
- Hui Zeng (ORCID: https://orcid.org/0000-0002-4498-8888)
- Huifang Yu
Institutions
- Jianghan University (CN)
- Wuhan No.1 Hospital (CN)
- Wuhan Sixth Hospital (CN)
- Hubei Cancer Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.3748/wjg.v30.i43.4609
- Citations
- 4
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- China Scholarship Council